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Hyperbranched poly(ethylenimine)s (HPEI) were modified with hydrophobic 
isobutyryl amide groups (HPEI-IBAm0.60) to cause an LCST. These modified polymers 
were then further substituted with hydrophobic alkyl chains (HPEI-IBAm0.60-R0.40), a 
mixture of alkyl chains and hydroxyethyl groups (HPEI-IBAm0.60-EtOH0.20-R0.20), and a 
mixture of alkyl chains and low molecular weight PEG (HPEI-IBAm0.60-PEG0.20-R0.20) to 
determine the effect of different functional groups on solubility behavior. At pH 7.4, all 
but three LCSTs were below body temperature (37 °C), while at pH 5, all but three 
LCSTs were above body temperature. The effect of the concentration of amines per gram 
of polymer (APG) on the solubility behavior was also investigated. The expected 
decrease in cytotoxicity from modifying primary amines to secondary amines, as well as 
the sensitivity to temperature and pH stimuli, makes these polymer systems strong 
candidates for non-viral gene delivery vectors.  
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1.  INTRODUCTION 
1.1  Gene Delivery 
Effective gene delivery provides scientists with the unique opportunity to actually 
correct mutated or disease-causing genes, rather than simply treating the effects of those 
genes. Gene delivery can either correct defective or mutated DNA by inserting an 
accurate strand of DNA or reactivate apoptosis in cells where the programmed-cell death 
pathway is not functioning properly, as in the case of cancer1. Drug delivery, on the other 
hand, transports drugs directly to cells, thus releasing the drugs only in cells. The 
detrimental and toxic side effects of drug therapy, caused by potentially harmful drugs 
dispersed equally among sick and healthy cells, are thereby decreased2.  
1.1.1  Applications 
Gene delivery is broadly applicable. Not only can gene delivery be used for 
disorders caused by genetic mutations, such as sickle cell anemia, it also offers possible 
cures for brain disease, like Parkinson’s and Alzheimer’s, and autoimmune issues, such 
as HIV3. Another prime area of interest is cancer, as gene delivery provides the ability to 
deliver apoptosis-inducing genes directly to tumors. Gene delivery is also being explored 
as a way to distribute DNA vaccines. 
1.2  The mechanism of gene delivery: Endocytosis 
While there are many mechanisms whereby particles traverse a cell wall, such as 
diffusion, through channels, or via active transport, endocytosis is the easiest pathway for 
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molecules that cannot enter via channels or diffusion. Endocytosis occurs when a cell 
extends a portion of its membrane around foreign objects, engulfing them in a vesicle, 
which then pinches off from the membrane and is released into the cytoplasm.  
Phagocytosis generally refers to endocytosis of large molecules and, at the 
mammalian level, is generally only performed by macrophages, cells related to the 
immune system4. Pinocytosis, sometimes referred to as cell drinking, is an indiscriminate 
engulfing of extra-cellular fluid and solutes5. This is the most likely method by which 
gene delivery vectors enter the cell. Entrance into the cell can also be effected through 
receptor-mediated endocytosis. In this case, the exterior of the cell membrane is lined 
with receptors for various molecules, such as proteins or carbohydrates. Thus, if the gene 
delivery vector was functionalized with molecules that had corresponding receptors on 
targeted cells, the vector could enter specific cells through this mechanism. 
 
 Scheme 1. Endocytosis 
Once the vesicle detaches from the cell wall, it joins with an endosome. As the 
endosome proceeds through the processing of received particles, the pH of the endosome 
decreases to between 6.0 and 4.86, with a typical value of pH 54, in a late endosome. At 
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the end of the pathway, an endosome either delivers its contents to a lysosome, which 
destroys the particles, or the DNA can escape from the endosome into the cytoplasm, 
whence DNA can enter the nucleus1 (Scheme 1).  
1.3  Gene delivery vectors 
While the first instinct may be to use naked DNA directly for gene therapy, gene 
delivery via naked DNA has many difficulties, caused primarily by the properties of 
DNA. Since DNA has a negatively charged backbone, due to the repeating phosphate 
groups throughout its structure (Figure 1), its journey through the hydrophobic interior of 
a cell membrane is severely hindered. The bulk added by its helical structure only further 
impedes DNA’s passage7.  
 
Figure 1. The structure of DNA, illustrating the negative charge on the backbone 
In addition to the problems caused by its structure, the ratio of DNA administered 
to DNA successfully delivered is fairly low1,8,9. DNA is often degraded by nucleases 
before it can reach the appropriate cells or integrate into the cellular DNA1. Finally, 
naked DNA allows no opportunity for targeting specific cells9. Thus, research into gene 
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and drug delivery has been largely devoted to discovering or designing effective carriers, 
or vectors, for transporting DNA into cells. 
1.3.1  Viral vectors 
Viral vectors are of especial interest for gene delivery, because they are already 
designed to penetrate the cell wall, release the viral DNA/RNA, and then hijack the host 
cell to copy the viral genes and synthesize the viral proteins7. In order to be used in the 
human body, the genes causing repeated replication must first be removed from the virus 
and replaced with the therapeutic DNA/RNA10. Because the natural ability to enter the 
cell and replicate the genes is retained, the viral vectors show high transfection 
efficiencies. In other words, a high percentage of the DNA carried in the virus is 
successfully integrated into the host DNA and expressed in the cell.  
 However, using a modified infection agent as a vector carries many risks. First, 
the body’s immune system views viruses, modified or unmodified, as foreign bodies that 
must be eliminated. Therefore, viral vectors are highly immunogenic1,9,11,12, which means 
they tend to induce a strong immune response with potentially serious side effects for the 
patients. Second, because a virus’s genome is fairly small, the size of DNA/RNA that can 
be integrated into a virus is rather limited 8,9,11,12. Thus, viral vectors are not effective 
therapeutic agents in cases concerning large, mutated DNA sequences. Third, some types 
of viral vectors can cause insertional mutagenesis10,12, which occurs when a base – 
adenine, cytosine, guanine, or thymine – is inserted into the DNA sequence. As a result, 
the code for the amino acids is completely changed, leading to the production of incorrect 
proteins and, possibly, cancer.  Finally, preparing the viral vectors is complicated, 
making them poor candidates for mass production8,9,11,12.  
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Some viruses overcome a few of these limitations, but the other drawbacks still 
remain prohibitive. For example, adeno-associated viruses (AAVs) and retroviruses have 
low immunogenicity. But AAVs can only carry very small DNA lengths, while 
retroviruses are unstable and much more likely to cause insertational mutagenesis9,10. 
Retroviruses are able to transfect only cells that are not proliferating, while other viruses, 
such as adenoviruses, AAVs, and lentiviruses have the advantageous capability of 
transfecting cells in any stage of reproduction, whether dividing or non-dividing8-10. 
Conversely, adenoviruses have high immunogenicity9,10, and lentiviruses can cause 
insertational mutagenesis10.  
1.3.2  Non-viral vectors 
In order to avoid the problems currently associated with viral vectors, many non-
viral vectors have been investigated. Principal non-viral carriers include cationic lipids, 
cationic polymers, and inorganic nanoparticles. Cationic lipids possess a hydrophilic, 
cationic head and long, hydrophobic carbon chains11 with an example shown in Figure 2.  
 
Figure 2. An inorganic nanoparticle modified with polymers and 1,2-dioleoyloxy-3-
trimethylammonium propane, a typical cationic lipid 
Cationic polymers usually contain positive charges directly on or pendent to the 
backbone. Typical inorganic nanoparticles investigated for gene delivery include gold, 
silicon oxide, iron oxide, and calcium phosphate particles, sometimes modified with 
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organic groups to improve transfection ability13. These methods offer many advantages 
for application in gene delivery.  
 First, unlike viral vectors, non-viral vectors are easy to manufacture, making large 
scale production a viable possibility1,9,11. Non-viral carriers are also easily modified to 
adjust the physical properties for optimum delivery capability1,13. By changing the 
functional groups on cationic lipids or polymers, the charge density, toxicity, and 
degradability can be increased or decreased. Bulky or non-bulky moieties or changes to 
the surface of a nanoparticle can alter the final morphology of a vector. Modifications can 
also affect the transfection ability. For example, by conjugating gold nanoparticles and 
poly(ethylenimine) (PEI), the transfection efficiency of PEI was significantly increased13. 
The ability to easily attach new groups means that targeting groups can be readily added 
to non-viral vectors, making the vectors particularly attractive to certain cells and 
allowing specific delivery of genes.  
Second, non-viral vectors have low immunogenicity, provoking little response 
from the immune system3,9,11,14. Cationic polymers and lipids are often either natural 
polymers or resemble biological molecules and thus trick the immune system into 
treating them as non-threatening molecules14. Most nanoparticles are highly 
biocompatible, especially if they are already found in the biological system. Calcium 
phosphate particles are commonly found in bone tissue and so appear normal to the 
immune system13.  
 Third, directly related to DNA–vector interactions, non-viral vectors place no 
limit on the length of DNA that can be delivered, since the vectors can effectively 
surround the DNA or the DNA strand can coil up to fit inside the vector, rather than 
 7 
actually integrating into a small viral genome8,9. Thus, a far broader range of diseases and 
mutations can be treated than is possible with viral delivery. For cationic polymers and 
lipids, because the DNA is packaged inside of the vector, it has good protection for its 
journey through the body, ensuring that it arrives intact within the cell1.  
 Unfortunately, non-viral vectors do have some disadvantages. First, while they do 
not provoke an immune response, some vectors, especially cationic lipids and polymers, 
are toxic to cells11,13. It is specifically the cationic nature of these vectors that seems to 
cause the toxicity, as the positive charges interact with slightly anionic components inside 
cells to prevent normal function11. Inorganic nanoparticles, however, tend to have fairly 
low toxicity13.  
 Second, transfection efficiencies in vivo for all non-viral vectors are significantly 
lower than for viral vectors or even naked DNA1,8,9,13. Since they lack the natural abilities 
of viruses to cross the cell wall and cause their genes to be processed into proteins, the 
difficulty lies in entering the cell and integrating the delivered DNA into cellular DNA.  
 Finally, because the DNA simply adheres to the surface of many inorganic 
nanoparticles, rather than being encapsulated inside them, the DNA is rather unprotected 
for its journey to the cell and faces many of the same problems as naked DNA13. Thus, 
even though nanoparticles have low toxicity, many still fail to effectively deliver genes.  
1.3.3  Characteristics of good non-viral gene delivery vectors 
While non-viral vectors hold much promise for gene delivery, they still lag behind 
viral vectors in many areas. In order, then, to work towards improving non-viral vectors, 
the characteristics of good non-viral vectors must first be established. First, non-viral 
vectors must possess high transfection efficiencies. This includes being able to enter a 
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cell via endocytosis and escape the endosomal pathway and degradation within the 
endosome15. From this point, in order to demonstrated a high gene expression, the DNA 
must be equipped to enter the nucleus and successfully produce the proteins encoded in 
it1. Second, both prior to entering the cell and within the cell, the vector must protect the 
DNA from enzymatic degradation1,3. Third, the non-viral vector should have low 
immunogenicity and low toxicity, and be biodegradable1. With these qualities the vector 
can effectively deliver the genes without harming the cell or remaining in the cell long-
term. Fourth, since a cell’s surface is anionic, vectors should be able to at least neutralize 
the negative charge on DNA’s backbone in order to avoid being repelled by the negative 
charge on the cell3. Finally, a non-viral vector must be able to condense the bulky DNA 
to a size small enough to enter the cell via endocytosis3,11.  
1.4  Cationic polymer vectors 
Because they already meet some of these requirements, cationic polymers as non-
viral vectors are of particular interest. First, because of the positive charge on their 
backbone, when they condense with DNA through electrostatic interactions, cationic 
polymers neutralize the anionic DNA and overcome the repulsion of the cell’s surface. 
Second, while cationic lipids can also neutralize DNA, these lipids are unstable, while 
cationic polymers are stable9. Third, cationic polymers can collapse the DNA into smaller 
complexes than cationic lipids can11,16,17.  
Finally, due to their size, cationic polymers can take advantage of an occurrence in 
cancerous tumors referred to as the “enhanced permeability and retention” (EPR) 
effect2,18. The EPR effect results from changes in the vascular and lymphatic systems 
within a tumor. While capillaries normally do not allow macromolecules to diffuse across 
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their walls into surrounding tissue, in both tumors and inflamed areas within the human 
body, the permeability of the capillaries is increased2,18. Thus, macromolecules are able 
to cross from within the capillaries into the interstitial spaces. This, in itself, is not 
necessarily problematic, as the lymphatic generally cleans these areas, carrying away the 
macromolecules. However, in tumors specifically, the lymphatic system does not 
function properly allowing the macromolecules to accumulate in the diseased tissue2,18. 
Therefore, the EPR effect, observed for macromolecules larger than 20 kDa2, provides 
natural targeting for gene delivery systems aimed particularly at cancer cells.  
1.4.1  Natural cationic polymers 
Cationic polymers can generally be divided into two categories. “Natural” 
polymers refer to those derived from molecules already found in nature, while synthetic 
polymers are discovered in laboratories. Of the many natural polymers studied for gene 
delivery, there are two that attract frequent attention: poly(L-lysine) and chitosan (Figure 
3). 
 
Figure 3. Common natural cationic polymers 
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Poly (L-lysine), one of the first polymers investigated for gene delivery, is 
polymerized from the amino acid, lysine, and is biodegradable. However, it possesses 
fairly low transfection efficiencies, even though it has a high cellular uptake, probably 
because it cannot effectively protect the genes while inside the endosome8,12. Chitosan, 
also nontoxic and biodegradable, is a linear aminopolysaccharide derived from chitin12. 
While chitosan does condense DNA to a very small size, like poly(L-lysine), it still has 
low transfection efficiency even though it effectively transports DNA into the cell due to 
the positive charges on the polymer backbone8,11,12,19.  
1.4.2  Synthetic cationic polymers 
There are many synthetic polymers also studied for gene delivery. In order to be 
cationic, they generally contain amine groups, either in the backbone or pendent. The 
amines also provide two additional benefits. First, they cause the polymers to look like 
legitimate biological molecules, such as amino acids, to the immune system, thus making 
them effective stealth molecules. Second, primary and secondary amines are reasonably 
good nucleophiles, thus cationic polymers are easy to modify via nucleophilic 
substitution. Most cationic polymers are related to one of three main groups; 
poly(dimethylaminoethyl methacrylate) (PDMAEMA), poly(amidoamine) (PAMAM) 
dendrimer, and poly(ethylenimine) (PEI) (Figure 4). 
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Figure 4. Important synthetic cationic polymers 
PDMAEMA is of particular interest, because it contains tertiary amines. Tertiary 
amines are stronger bases than primary or secondary amines, and so are better able to 
protect the DNA from the acidic environment within the endosome. PDMAEMA has also 
demonstrated higher transfection efficiencies than PEI. However, PDMAEMA is still 
cytotoxic and the polyplexes remain in the endosome even after 24 hours12.  PAMAM is 
often found in dendrimer form, generally with cations capping the branches. Thus it more 
effectively encapsulates and protects the DNA from nucleases. However, as the amount 
of branching, and thus the cationic character, increases, so does the toxicity19,20.  
1.5  Poly(ethylenimine) 
There are two types of PEI typically used for gene delivery – linear and branched 
(HPEI). Of the two, HPEI generally transfects cells better than linear PEI, and so is more 
often studied21. Due to the high concentration of amines – one amine for every two 
carbons – HPEI has a high charge-to-mass ratio, giving it three important advantages as a 
gene delivery vector.  
First, HPEI is especially good at condensing DNA due to the strong attraction 
between the many cations on the polymer and the anions on the DNA backbone. Second, 
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the excess positive charge increases the attraction of the polyplexes to the anionic cell 
membrane surface, which facilitates high rates of endocytosis. Finally, HPEI also excels 
in helping the genes to escape from the acidic environment within endosomes. The large 
quantity of amines makes HPEI an effective buffer, allowing it to act as a proton 
sponge7,22. Once an endosome is formed, proton pumps in its wall start pushing in large 
quantities of protons to create an acidic environment, which is the ideal surrounding for 
nucleases to function. Since HPEI is a buffer, as protons enter the endosome, the neutral 
amines act as bases and become protonated, thus moderating the acidity and allowing 
only a slight drop in pH. Because the pH is not low enough, protein folding within the 
vacuole might be altered, preventing the normal function of nucleases and thus protecting 
the DNA/RNA from degradation21. In order to reach the desired pH, the proton pumps 
continues to bring in more protons, which HPEI continues to absorb. As a result, the 
positive charges build up on the polymer and repel each other, causing HPEI to expand 
like a sponge (Scheme 2). 
 
Scheme 2. The proton sponge effect of HPEI acting as a buffer. 
At the same time, chloride anions are entering the endosome as counter ions. In 
response to the higher than usual concentration of charges within the endosome, water 
diffuses across the endosomal membrane to decrease the concentration (Scheme 2). The 
 13 
combination of swelling HPEI and excess water within the endosome ruptures it, 
releasing the DNA into the cytoplasm22,23.  
The molecular weight of HPEI affects both the transfection efficiency and the 
toxicity of the polymer. As the molecular weight increases, so does the overall 
transfection efficiency21,24, probably due to the increasing amount of positive charge. 
However, an augmentation in toxicity also accompanies the increase in molecular weight 
and cationic nature21,25. Thus, a balance must be struck between transfection efficiency 
and toxicity, which explains the attraction of the commercially available molecular 
weight of 25kDa. While this size still shows high toxicity, modifications to the amines on 
HPEI, especially primary amines, can help to decrease the toxicity12. 
1.5.1  Modifications to PEI 
There are two common group types used to modify HPEI. First, hydrophobic 
groups bring many potential advantages to gene delivery vectors, though the effects tend 
to vary depending on the polymer and hydrophobic group. Due to the length and 
flexibility of hydrophobic portions, they help to physically surround the DNA, rather than 
protecting it only via electrostatic attractions. Hydrophobic moieties also increase the 
attraction of the polyplex to the lipid cell membrane, thus increasing the transfection 
efficiency26. Depending on the percent modification, hydrophobicty, and structure of the 
added functional groups, the cytotoxicity of the polymer vector can be decreased. 
However, there does not seem to be a linear correlation of cytotoxicity decreasing as 
hydrophobicity increases12,26. Second, poly(ethyleneglycol) (PEG) modified HPEI has 
also been shown to increase transfection efficiency and decrease toxicity, as the PEG 
chains cover the positive surface charge on the polyplexes12. 
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1.6  Stimuli responsive polymers 
Stimuli responsive polymers, or smart polymers, are another subset of non-viral 
gene delivery vectors that offers the additional advantage of controlled release of 
therapeutic materials, whether genes or drugs. Smart polymers are capable of changing 
their chemical and physical, or conformational, properties in response to small external 
signals27,28. Their abilities to bind and encapsulate or release molecules, and alter their 
shape are singularly applicable to gene delivery. Light, pH, and temperature responsive 
polymers are typically studied as non-viral vectors.  
1.6.1  Light responsive polymers 
There are two common responses to ultraviolet light – either a conformational 
change or cleavage of a bond. When irradiated with ultraviolet light, azobenzene absorbs 
a photon and is excited from the lower energy trans form to the higher energy cis form 
(Scheme 3).  
 
Scheme 3. Reversible switch from trans to cis of azobenzene 
Azobenzene derivatives can be used in conjunction with polymers to change the 
physical properties of the host polymer. Pillar[6]arene is a cyclic oligomer, which when 
modified with triethylene oxide groups (Figure 5) becomes water-soluble and develops a 
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lower critical solution temperature (LCST). An LCST is a reverse switching temperature 
for solubility – below the LCST a material is soluble, while above the LCST it is 
insoluble. When trans azobenzene molecules, modified with two 1,4-
diazabicyclo[2.2.2]octane (DABCO) (Figure 5), were added to the solution, the LCST 
increased as the azobenzene derivatives threaded through the cyclic oligomers and 
increased the order of the solution. However, when the solution was irradiated with 
ultraviolet light, the azobenzene derivatives switched to the cis form, and no longer fit 
through the rings. Thus, aggregation occurred sooner and the LCST decreased29.  
 
Figure 5. A) Azobenzene modified with DABCO and B) Pillar[6]arene 
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If azobenzene could be functionalized with drugs, in the same fashion that it was 
functionalized with DABCO, this system could be used for drug delivery. At one 
temperature, the drug could be both protected inside the pillar[6]arene and later released 
upon site specific exposure to ultraviolet light.  
1.6.2  pH responsive polymers 
pH responsive polymers are created by synthesizing poly(acid)s or poly(base)s. 
Thus, as the pH of the solution is changed, the polymers become protonated or 
deprotonated creating positive and negative charges along the backbone and affecting 
both conformation and solubility. First, the charges repel each other, pushing the polymer 
apart and changing the conformation from a compact globule to an elongated coil 
(Scheme 4).  
 
 
Scheme 4. Transition from globule to coil 
Second, the solubility is also affected as the increasing charge makes the 
polymers, in effect poly(electrolyte)s, more soluble in aqueous solutions. The solubility 
can also be influenced by functional groups on the polymers, as hydrophobic groups will 
decrease solubility while hydrophilic groups will increase solubility in water.  
Poly(!-amino ester), a poly(base) with a pKb around 6.530, is soluble in solutions 
below pH 6.5, because it is protonated. However, as the pH becomes basic, the polymer 
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is deprotonated and becomes insoluble in water. Poly(ethyleneglycol) methyl ether 
(MPEG) was added as block copolymer (Figure 6) in order to provide a protective 
hydrophilic shell to the globule formed in basic conditions30. The shell helps to protect 
the polyplex of polymer and DNA from degradation within the body30,31.  
 
Figure 6. pH responsive MPEG-poly(!-amino ester) block copolymer 
Because the MPEG is hydrophilic, it also increases the switching pH to at least 
pH 7.2, depending on the ratio of MPEG added30. Thus, this polymer can be used for 
gene delivery since at physiological pH it is clamped down in the globule form, capable 
of protecting DNA, but at the lower pH within endosomes the polymer can open up to the 
coil form, releasing the DNA. 
1.6.3  Temperature responsive polymers 
Like pH responsive polymers, many temperature responsive polymers also 
experience a conformational change from globule to coil depending on temperature. The 
switch occurs as a result of an LCST, and depends on the ratio of hydrophobic to 
hydrophilic groups. Poly(N-isopropylacrylamide) (PNIPAAM), a common example of a 
thermo-responsive polymer, demonstrates an LCST between 30-34°C32, because of the 




Figure 7. PNIPAAM 
Since PNIPAAM is in the globule form at normal body temperature (37°C), it can 
effectively encapsulate DNA or drugs for delivery and rely on degradation in extremely 
acidic environments, such as the stomach, to release its contents. 
1.7  Mechanism of LCST behavior 
An LCST usually arises in polymers functionalized with hydrophobic groups, 
introducing two competing forces into solubility. While the hydrophilic portions are 
attracted to the water molecules, at the same time the water molecules repulse the 
hydrophobic portions of the polymer. Which of these forces will determine the solubility 
changes depending on the temperature of the solution and is related to the Gibbs’ free 
energy of mixing (!G = !H – T!S). The formation of hydrogen bonds and polar 
attractions with water stabilizes the polymer and releases energy, making a negative 
(favorable) contribution to the enthalpy of mixing14. However, while the hydrophilic 
portion is solvated, the solution is more orderly and makes an unfavorable entropy 
contribution to the free energy of mixing. As temperature increases break hydrogen 
bonds, the entropy term carries more weight and eventually offsets the enthalpy term, 
causing the solution to phase separate and become more disorderly14,33. The phase 
separation occurs as the hydrophilic portion of the polymer is no longer hydrated and 
collapses from an extended coil to a globule. These globules then aggregate together, 
separating from the water33. 
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1.7.1  Factors affecting LCST 
There are different factors that can change the temperature at which the LCST 
occurs. First, the ratio of hydrophilic groups to hydrophobic groups plays a major role. If 
the ratio is larger, then there are more hydrogen bonds that can be formed and greater 
polar interactions with water, thus increasing the LCST as the favorable enthalpy 
contribution is larger. Conversely, if the ratio is smaller, the polymer will have fewer 
attractions to water and will become insoluble at a lower temperature. Second, pH can 
affect the LCST if the polymer contains acid or base moieties. For example, a basic 
polymer would become more protonated as the pH decreases, thus developing positive 
charges and becoming more ionic in character. As a result, the cations will be more 
strongly attracted to water than the neutral polymer, thus increasing the LCST. 
This phenomenon allows the interactions between the basic polymer and the DNA 
to be altered at a single temperature by varying the pH (Scheme 5).  
 
 Scheme 5. Effect of temperature and pH on polyplexes 
 As the temperature increases, the polymer collapses to the globule form and 
clamps down on the DNA. However, if the pH is decreased, the LCST increases, re-
expanding the polymer to the coil conformation and releasing the genes.  
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1.8  Previous work 
Liu et al. worked to design a structural isomer of PNIPAAM by the addition of 
isobutyryl amide groups to HPEI (Figure 8)34.  
 
Figure 8.  Amidated HPEI 
They found that amidated HPEI (HPEI-IBAm), like PNIPAAM, is a temperature 
responsive polymer that demonstrates an LCST. Unlike PNIPAAM, due to the nitrogens 
in the backbone that can be protonated, HPEI-IBAm is also responsive to pH changes 
(Scheme 5). The LCST of this polymer can also be tailored by modifying the percent of 
amide groups added. Liu et al. studied 70% and 100% amidated HPEI at varying pHs, 
which led to LCSTs ranging from approximately 12°C – 65°C.  
Previous members of our group synthesized a series of polymers with varying 
percent alkylation and percent amidation. Polymers with increasing hydrophobicity from 
alkyl chains generally manifested a decrease in their LCST35. It was also shown that as 
the percent of amide groups increased, the LCST decreased due to the increasing 
hydrophobic character of the polymer36. Solution properties also affected the LCST. As 
the weight percent of the polymer in solution decreased, the LCST increased since the 
lower concentration made it more difficult for the polymer to aggregate36. The 
concentration of salt in the solution decreased the LCST, as less of the water molecules 
were free to solvate the polymer, being more strongly attracted to the ionic particles36. 
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One polymer was also made that was amidated and hydroxyethylated. As would be 
expected from the increasing hydrophilicity, the LCST did increase slightly compared to 
the amidated polymer36. 
1.9  Current work 
The goal of this project was to improve transfection efficiency, decrease toxicity, 
and tune the LCST of HPEI-IBAm through modification with different functional groups. 
Part of the goal in investigating the LCST was to determine what effect solubility 
behavior has on transfection efficiency. For example, does an abrupt release caused by a 
rapid change in solubility transfect cells better than a gradual release cause by a slow 
change in solubility? A second part of improving transfection is related to the ability of 
the polymer vector to carry the genes across the cell wall. Since the cell wall contains a 
hydrophobic interior, modification with hydrophobic functional groups, such as alkyl 
chains, could improve the endocytosis process. The addition of long functional groups, 
whether hydrophobic or hydrophilic, can also improve cytotoxicity by shielding the 
positive charges on HPEI. Third, modification with long chains allows the opportunity to 
add a targeting group that will be more exposed to the cell receptors than if it were 
hidden on the polymer backbone. However, the beneficial effects of targeting groups and 
decreased cytotoxicity must be balanced with the effect of these functional groups on the 
LCST. 
As the first step in this project, then, the effect on solubility behavior of increasing 
hydrophobicity was to be determined. Next, the hydrophobic groups were to be tempered 
with a small hydrophilic group in order to provide greater control over solubility 
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behavior. Finally, the effect of PEG and PEG mixed with hydrophobic groups was to be 
studied. 
 23 
2.  EXPERIMENTAL 
2.1  Instrumentation 
1H and 13C Nuclear Magnetic Resonance (NMR) spectra were recorded on a 
Bruker AVANCE 300 MHZ instrument operating at 300 and 75.5 MHz, respectively. 
Samples were dissolved in D2O or CDCl3 at a concentration of (~ 30 mg / 0.7 mL). 
Samples were dried using a Savant Speed-Vac (SC110) with attached Refrigerated Vapor 
Trap (RVT4104). Transmittance data were obtained on a Hewlett Packard 8453 
Ultraviolet-visible spectrometer with an external heating source. 
2.2  Materials 
Hyperbranched polyethylenimine (HPEI), Lupasol® WF (BASF, Mn = 
10,000g/mol), was dried in vacuo using the speed vacuum prior to use. Triethylamine 
(TEA, Sigma-Aldrich, 99%) and dimethyl sulfoxide (DMSO, Sigma-Aldrich, 99%) were 
dried over CaH2 and distilled under nitrogen. Isobutyryl chloride (Sigma-Aldrich, 98%) 
was distilled under nitrogen. Anhydrous tetrahydrofuran (THF, Sigma-Aldrich, 99.9%), 
2-bromoethanol (Sigma-Aldrich, 95%), 1-bromobutane (Sigma-Aldrich, ReagentPlus 
99%), 1-bromohexane (Sigma-Aldrich, 98%), 1-bromooctane (Sigma-Aldrich, 99%), 1-
bromododecane (Sigma-Aldrich, 97%), and poly(ethylene glycol) methyl ether tosylate 
(TPEG, Sigma-Aldrich, Mn = 900g/mol) were used as received. Reagent-grade anhydrous 
potassium carbonate powder (K2CO3, Sigma-Aldrich, 99%) was dried at 130 °C in an 
oven prior to use. Ethanol (EtOH, Decon Laboratories) and methanol (MeOH, Fischer 
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Scientific) were used as received. Sodium hydroxide (NaOH, VWR) and hydrochloric 
acid (HCl, Macron) were used as received. All water utilized was ultra-purified via a 
three-step purification process. Initially, the water went through Wright State’s reverse 
osmosis system, followed by an ion-exchange-membrane provided by Dayton Water 
Company. Finally, it was passed through a 5 filter (carbon, deionization, deionization, 
organic absorption, and ultra violet) Labconco Water Pro Plus system. 
2.3  Synthesis of HPEI-IBAm0.60 
To an oven-dried 500 mL RBF with septum inlet equipped with water condenser, 
nitrogen inlet, and stir bar were added 2.00 g (33.9 mmol of modifiable amines) of dried 
HPEI, 40.0 mL (287 mmol) TEA, and 300 mL anhydrous THF. The flask was cooled to 
0°C in an ice bath. Then 2.13 mL (20.3 mmol) of distilled isobutyryl chloride were added 
dropwise under vigorous stirring. The mixture was allowed to warm to room temperature 
overnight and then heated to 50°C for 30 minutes. The solvent was evaporated in vacuo, 
the residue was dissolved in DDI H2O and placed in aqueous dialysis for 48 hours. The 
water was then evaporated using the speed-vacuum to afford 2.70 g (79%) of a pale 
yellow, glassy material. 1H-NMR (D2O, "):  0.98 (s, 6H), 2.33-3.54 (broad, 13H). 13C-
NMR (D2O, "): 18.9, 30.0, 35.0, 37.5, 45.4-51.0. 
2.4  Synthesis of HPEI-IBAm0.60-Bu0.18 
In an oven-dried 5 mL RBF, equipped with a stir-bar, water condenser, and 
nitrogen inlet, 0.150 g (0.590 mmol of modifiable amines) of HPEI-IBAm0.60 were 
dissolved in 0.90 mL of THF. The RBF was placed in a 65°C preheated oil bath and 67 
µL (0.619 mmol) of 1-bromobutane were added. After 48 hours the reaction was 
quenched with 0.0252 g (0.619 mmol) of NaOH dissolved in 0.25 mL of MeOH. After 24 
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hours the solvent was evaporated and the residue dissolved in DDI H2O. Dialysis was 
done in DDI H2O for 48 hrs. The water was then evaporated using the speed-vacuum to 
give 0.118 g (64.5%) of a dark yellow glassy solid. 1H-NMR (D2O, "):  0.87 (s, 3H), 1.01 
(s, 6H), 1.31 (s, 2H), 1.62 (s, 2H), 2.36-3.59 (broad, 15H). 
2.5  Synthesis of HPEI-IBAm0.60-Bu0.64 
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.156 g (2.11 mmol of modifiable amines) of HPEI-IBAm0.60 were dissolved in 
0.90 mL of EtOH. Then 0.128 g (0.926 mmol) of K2CO3 were added, and the RBF was 
placed in a 65°C preheated oil bath. Then 68 µL (0.573 mmol) of 1-bromobutane were 
added. After 72 hours the reaction mixture was cooled, dissolved in DDI H2O, and placed 
in aqueous dialysis for 48 hours. The water was then evaporated using the speed-vacuum 
to afford 0.0759 g (33.5%) of a yellow glass solid. 1H-NMR (D2O, "):  0.92 (s, 3H), 1.03 
(s, 6H), 1.37 (s, 2H), 1.68 (s, 2H), 2.39-3.67 (broad, 15H). 
2.6  Synthesis of HPEI-IBAm0.60-Bu0.40 delayed addition of K2CO3 
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.136 g (1.84 mmol of modifiable amines) of HPEI-IBAm0.60 were dissolved in 
0.78 mL of EtOH. The RBF was placed in a 65°C preheated oil bath and then 60 µL 
(0.538 mmol) of 1-bromobutane were added. After 48 hours, 0.111 g (0.806 mmol) of 
K2CO3 were added. After 24 hours, the reaction mixture was cooled, dissolved in DDI 
H2O, and placed in aqueous dialysis for 48 hours. The water was then evaporated using 
the speed-vacuum to afford 0.145 g (88%) of a solid yellow gel. 1H-NMR (D2O, "):  0.87 
(s, 3H), 1.01 (s, 6H), 1.24 (s, 2H), 1.57 (s, 2H), 2.40-3.59 (broad, 15H). 13C-NMR (D2O, 
"):  13.21, 18.92, 20.15, 27.67, 29.95, 35.05, 36.37-37.79, 43.37-53.94. 
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2.7  Synthesis of HPEI-IBAm0.60-He0.28 
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.145 g (1.96 mmol of modifiable amines) of HPEI-IBAm0.60 were dissolved in 
0.85 mL of EtOH. Then 0.119 g (0.860 mmol) of K2CO3 were added and the RBF was 
placed in a 65°C preheated oil bath. Then 83 µL (0.573 mmol) of 1-bromohexane were 
added. After 72 hours the reaction mixture was cooled, dissolved in DDI H2O, and placed 
in aqueous dialysis for 48 hours. The water was then evaporated using the speed-vacuum 
to afford 0.178 g (98%) of a yellow glassy solid. 1H-NMR (D2O, "):  0.80 (s, 3H), 1.01 
(s, 6H), 1.26 (s, 6H), 1.68 (s, 2H), 2.38-3.69 (broad, 15H). 
2.8  Synthesis of HPEI-IBAm0.60-He0.40 delayed addition of K2CO3  
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.128 g (1.74 mmol of modifiable amines) of HPEI-IBAm0.60 were dissolved in 
0.74 mL of EtOH. The RBF was placed in a 65°C preheated oil bath. Then 75 µL (0.507 
mmol) of 1-bromohexane were added. After 48 hours, 0.105 g (0.764 mmol) of K2CO3 
were added. After 24 hours, the reaction mixture was cooled, dissolved in DDI H2O, and 
placed in aqueous dialysis for 48 hours. The water was then evaporated using the speed-
vacuum to afford 0.0321g (14%) of a solid yellow gel. 1H-NMR (D2O, "): 0.80 (s, 3H), 
1.01 (s, 6H), 1.25 (s, 6H), 1.68 (s, 2H), 2.38-4.05 (broad, 15H). 13C-NMR (D2O, "):  
13.76, 18.90, 22.04, 23.16, 25.30, 30.00, 35.03, 37.58, 41.84-54.84. 
2.9  Synthesis of HPEI-IBAm0.60-Oc0.24 
In an oven-dried 5 mL RBF, equipped with a stir-bar, water condenser, and 
nitrogen inlet, 0.149 g (0.587 mmol of modifiable amines) of HPEI-IBAm0.60 were 
dissolved in 0.90 mL of THF. The RBF was placed in a 65°C preheated oil bath. 0.107 
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mL (0.617 mmol) of 1-bromooctane were added. After 48 hours the reaction was 
quenched with 0.0244 g (0.617 mmol) of NaOH dissolved in 0.24 mL of MeOH. After 24 
hours the solvent was evaporated and the residue dissolved in DDI H2O. Dialysis was 
done in DDI H2O for 48 hrs. The water was then evaporated using the speed-vacuum to 
give 0.194 g (90.7%) of a dark yellow reddish glassy solid. 1H-NMR (D2O, "):  0.81 (s, 
3H), 1.01 (s, 6H), 1.22 (s, 10H), 1.59 (s, 2H), 2.42-3.86 (broad, 15H). 13C-NMR (D2O, 
"):  13.91, 19.07, 22.56, 25.68, 29.95, 35.00-35.16, 35.50-37.70, 43.32-53.09. 
2.10  Synthesis of HPEI-IBAm0.60-DoDec0.24 
In an oven-dried 5 mL RBF, equipped with a stir-bar, water condenser, and 
nitrogen inlet, 0.137 g (0.539 mmol of modifiable amines) of HPEI-IBAm0.60 were 
dissolved in 0.83 mL of THF. The RBF was placed in a 65°C preheated oil bath. 0.137 
mL (0.567 mmol) of 1-bromododecane were added, causing the polymer to form a ball. 
The following day, 0.3 mL of EtOH were added to fully dissolve the polymer. After 48 
hours the reaction was quenched with 0.0227 g (0.567 mmol) of NaOH dissolved in 0.25 
mL of MeOH. After 24 hours the solvent was evaporated and the residue dissolved in 
DDI H2O. Dialysis was done in DDI H2O for 48 hrs. The water was removed with the 
speed-vacuum to give 0.165 g (73%) of a yellow brown viscous gel. 1H-NMR (D2O, "): 
0.82 (s, 3H), 1.01 (s, 6H), 1.23 (s, 18H), 1.75 (s, 2H), 2.41-3.69 (broad, 15H). 13C-NMR 
(CDCl3, "): 14.1, 19.7, 22.6, 29.4, 31.9, 35.3, 46.0-52.3, 178.1. 
2.11  Synthesis of HPEI-IBAm0.64-EtOH0.18-Bu0.18 
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.250 g (2.42 mmol of modifiable amines) of HPEI-IBAm0.64 were dissolved in 
1.5 mL THF. The RBF was placed in a 65°C preheated oil bath. Then, 50 µL (0.467 
 28 
mmol) of 1-bromobutane were added. After 48 hours the reaction was quenched with 
0.0187 g (0.467 mmol) of NaOH in 0.19 mL of MeOH and allowed to stir for 24 hours. 
After 24 hours the solvent was evaporated and the residue was redissolved in EtOH in the 
same flask. Then, 0.033 mL (0.467 mmol) of 2-bromoethanol were added. After 48 hours 
the reaction was quenched with 0.0190 g (0.467 mmol) of NaOH in 0.19 mL of MeOH 
and allowed to stir for 24 hours, at which point the solvent was evaporated, the residue 
was dissolved in DDI H2O and placed in aqueous dialysis for 48 hours. The water was 
then evaporated using the speed-vacuum to afford 0.0990 g (33.4%) of a dark yellow-
brownish glassy solid. 1H-NMR (D2O, "): 0.91 (s, 3H), 1.02 (s, 6H), 1.33 (s, 2H), 1.65 (s, 
2H), 2.42-4.02 (broad, 20H). 
2.12  Synthesis of HPEI-IBAm0.60-EtOH0.20-He0.20 
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.143 g (1.42 mmol of modifiable amines) of HPEI-IBAm0.60 were dissolved in 
0.83 mL EtOH. The RBF was placed in a 65°C preheated oil bath and 20 µL (0.284 
mmol) of 2-bromoethanol were added. After 48 hours the reaction was quenched with 
0.0113 g (0.281 mmol) of NaOH in 0.11 mL of MeOH. After 24 hours 40 µL (0.284 
mmol) of 1-bromohexane were added to the same flask. After 48 hours the reaction was 
quenched with 0.0113 g (0.284 mmol) of NaOH in 0.11 mL of MeOH and allowed to stir 
for 24 hours, at which point the reaction solution was dissolved in DDI H2O, and placed 
in aqueous dialysis for 48 hours. The water was then evaporated using a Savant speed-
vacuum system to afford (72.5%) of a yellow glassy solid. 1H-NMR (D2O, "):  0.81 (s, 
3H), 1.00 (s, 6H), 1.25 (s, 6H), 1.63 (s, 2H), 2.37-4.09 (broad, 20H). 13C-NMR (D2O, "):  
13.39, 18.95, 21.79, 25.47, 29.95, 30.53, 35.03, 36.09-37.85, 43.32-59.96. 
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2.13  Synthesis of HPEI-IBAm0.60-EtOH0.20-Oc0.20 
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.142 g (1.41 mmol of modifiable amines) of HPEI-IBAm0.60 were dissolved in 
0.48 mL EtOH. The RBF was placed in a 65°C preheated oil bath and 20 µL (0.281 
mmol) of 2-bromoethanol were added. After 48 hours the reaction was quenched with 
0.0112 g (0.281 mmol) of NaOH in 0.11 mL of MeOH. After 24 hours 49 µL (0.281 
mmol) of 1-bromooctane were added to the same flask. After 48 hours the reaction was 
quenched with 0.0112 g (0.281 mmol) of NaOH in 0.11 mL of MeOH and allowed to stir 
for 24 hours, at which point the solvent was evaporated, the residue was dissolved in DDI 
H2O, and placed in aqueous dialysis for 48 hours. The water was then evaporated using a 
Savant speed-vacuum system to afford 0.153 g (82.7%) of a dark yellow-brownish 
viscous gel. 1H-NMR (D2O, "):  0.79 (s, 3H), 0.97 (s, 6H), 1.20 (s, 10H), 1.40 (s, 2H), 
2.37-4.04 (broad, 20H). 13C-NMR (D2O, "): 14.0, 19.0, 22.6, 29.3, 30.5, 31.9, 35.0, 
29.3-37.8, 43.7-59.2, 62.6, 72.0, 180.7.  
2.14  Synthesis of HPEI-IBAm0.63-EtOH0.19-DoDec0.18 
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.145 g (1.43 mmol of modifiable amines) of HPEI-IBAm0.63 were dissolved in 
0.48 mL of ethanol. The RBF was placed in a 65°C preheated oil bath. Then 19 µL 
(0.267 mmol) of 2-bromoethanol were added. After 48 hours the reaction was quenched 
with 0.0107 g (0.267 mmol) of NaOH in 0.107 mL of MeOH. After 24 hours 61 µL 
(0.253 mmol) of 1-bromododecane were added. After 48 hours the reaction was 
quenched with 0.0101 g (0.253 mmol) of NaOH in 0.101 mL of MeOH. After 24 hours 
the solvent was evaporated and the residue dissolved in DDI H2O and placed in aqueous 
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dialysis for 48 hours. The water was then evaporated using a Savant speed-vacuum 
system to afford 0.153 g (77%) of a yellow glassy solid. 1H-NMR (D2O, "):  0.81 (s, 3H), 
1.00 (s, 6H), 1.21 (s, 20H), 2.41-4.08 (broad, 20H). 
2.15  Synthesis of HPEI-IBAm0.60-PEG0.25 
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.158 g (2.14 mmol of modifiable amines) of HPEI-IBAm0.60 were dissolved in 
1.3 mL of DMSO. Then 0.130 g (0.939 mmol) of K2CO3 were added and the RBF was 
placed in a 65°C preheated oil bath. Then 0.599 g (0.664 mmol) of TPEG in 0.2 mL of 
DMSO were added. After 72 hours the reaction mixture was cooled, dissolved in DDI 
H2O, and placed in aqueous dialysis for 48 hours. The water was then evaporated using 
the speed-vacuum to afford 0.246 g (57%) of a brownish viscous gel. 1H-NMR (D2O, "):  
1.02 (s, 6H), 2.34 (s, 1H), 2.41-4.16 (broad, 16H), 3.32 (s, 3H), 3.64 (s, 64H). 13C-NMR 
(D2O, "):  18.93, 29.93, 35.08, 37.21-38.79, 41.98-53.54, 58.09, 63.71-66.52, 69.62, 
71.03. 
2.16  Synthesis of HPEI-IBAm0.60-PEG0.23-Bu0.17 
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.127 g (0.513 mmol of modifiable amines) of HPEI-IBAm0.60-PEG0.23 were 
dissolved in 0.3 mL of EtOH. Then 0.0213 g (0.154 mmol) of K2CO3 were added. The 
RBF was placed in a 65°C preheated oil bath. Then 11 µL (0.103 mmol) of 1-
bromobutane were added. After 72 hours the reaction mixture was cooled, dissolved in 
DDI H2O, and placed in aqueous dialysis for 48 hours. The water was then evaporated 
using the speed-vacuum to afford 0.121 g (85%) of a brownish viscous gel. 1H-NMR 
(D2O, "):  0.89 (s, 3H), 1.02 (s, 6H), 1.26 (s, 2H), 1.38 (s, 2H), 2.41-4.16 (broad, 15H), 
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3.32 (s, 3H), 3.64 (s, 64H). 13C-NMR (D2O, "):  13.35, 18.96, 25.17, 29.97, 35.01, 36.59-
37.77, 42.49-47.51, 49.14-51.67, 52.16-53.88, 58.01, 69.6, 71.03. 
2.17  Synthesis of HPEI-IBAm0.60-PEG0.25-Oc0.15 
 In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.162 g (0.595 mmol of modifiable amines) of HPEI-IBAm0.60-PEG0.26 were 
dissolved in 0.3 mL of EtOH. The RBF was placed in a 65°C preheated oil bath. Then 15 
µL (0.0893 mmol) of 1-bromooctane were added. After 48 hours, 0.0195 g (0.0893 
mmol) of K2CO3 were added. After 24 hours, the reaction mixture was cooled, dissolved 
in DDI H2O, and placed in aqueous dialysis for 48 hours. The water was then evaporated 
using the speed-vacuum to afford 0.143 g (81%) of a dark brown glassy solid. 1H-NMR 
(D2O, "): 0.83 (s, 3H), 1.00 (s, 6H), 1.23 (s, 12H), 3.30 (s, 3H), 3.62 (s, 64H), 2.36-4.14 
(broad, 15H). 
2.18  Synthesis of HPEI-IBAm0.60-PEG0.23-DoDec0.17 
In an oven-dried 5 mL RBF, equipped with water condenser, nitrogen inlet, and 
stir bar, 0.106 g (0.387 mmol of modifiable amines) of HPEI-IBAm0.60-PEG0.23 were 
dissolved in 0.3 mL of EtOH.  The RBF was placed in a 65°C preheated oil bath. Then 16 
µL (0.0658 mmol) of 1-bromobutane were added. After 48 hours, 0.0135 g (0.0658 
mmol) of K2CO3 were added. After 24 hours, the reaction mixture was cooled, dissolved 
in DDI H2O, and placed in aqueous dialysis for 48 hours. The water was then evaporated 
using the speed-vacuum to afford 0.102 g (90%) of a medium brown glassy solid. 1H-
NMR (D2O, "):  0.84 (s, 3H), 1.01 (s, 6H), 1.22 (s, 20H), 3.31 (s, 3H), 3.62 (s, 64H), 
2.36-4.17 (broad, 20H). 
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2.19  Characterization 
2.19.1  General procedure for determining LCST 
Transmittance data were obtained at 500 nm, at a heating rate of 1 °C min-1 under 
air. Polymers were dissolved in DDI water at a concentration of 2 wt. %. Dilute HCl and 
NaOH were used to adjust the pH to 7.4 or 5. The LCST was defined as the temperature 
corresponding to the 50% transmittance in the resulting transmittance versus temperature 
curves. 
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3.  RESULTS AND DISCUSSION 
Three different polymer series were synthesized in order to study the effect of 
different functional groups on solubility behavior and to pave the way for further 
transfection studies and eventual modification with targeting groups. First, an amidated 
HPEI polymer was synthesized and used as the foundation for all further modifications. 
Second, a series of polymers modified with increasing lengths of hydrophobic alkyl 
chains, namely butyl, hexyl, octyl, and dodecyl, was prepared and characterized. Third, 
another series was synthesized containing an equal split between the same alkyl chains 
and a hydroxyethyl group. Finally, the polymer form of hydroxyethyl, 
poly(ethyleneglycol) (PEG), was used to prepare an analogous series of mixed alkyl and 
PEG modifications.  
The HPEI used from BASF contains primary, secondary, and tertiary amines in a 
ratio of 1:1.20:0.7637. Tertiary amines are not available for modification, because attack 
at a tertiary amine would lead to an unstable quaternary ammonium species. Since only 
primary and secondary amines are available for modification via SN2 reactions, 73% of 
the amines in HPEI can be modified. All percent modifications are calculated as 
percentages of this initial 73%.  
3.1  Characterization and transmission of HPEI-IBAm0.60 
The first step was to create the structural isomer of PNIPAAM by amidating HPEI 
with isbutyryl chloride. The goal was to introduce enough hydrophobicity to cause a 
LCST below 37°C at pH 7.4, but leave sufficient primary and secondary amines available 
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for further modification with other functional groups. The procedure from Liu et al34was 
followed with minor modifications, as shown in Scheme 6, to prepare 60% amidated 
HPEI (HPEI-IBAm0.60). HPEI was dissolved in a mixture of TEA and anhydrous THF, 
cooled to 0°C in an ice bath, and then isobutyryl chloride was added dropwise. After 
warming to room temperature overnight, the reaction mixture was heated to 50°C for 30 
minutes to finalize the reaction. After cooling, the solvent was evaporated and the residue 
dissolved in deionized water and purified by dialysis.  
 
 
Scheme 6. Synthesis of HPEI-IBAm0.60 (1) 
1H-NMR and 13C-DEPT 135 NMR spectroscopy were used to characterize the 
product. Compared to the 1H-NMR spectrum of HPEI (Figure 9), two differences are 
seen in the peaks from the backbone hydrogens at 2.56-2.63 ppm. First, the peaks 
broaden, due to the presence of slightly different chemical environments. Second, a new 
set of backbone peaks develops slightly downfield at 3.05-3.57 ppm, as the hydrogens are 
more deshielded by the electron withdrawing amide groups. A new peak appears at 0.98 
ppm from the methyl hydrogens on the amide groups. 
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Figure 9. 300 MHz 1H-NMR spectral (D2O) overlay of HPEI and HPEI-IBAm0.60 (1) 
The percent modification of HPEI was calculated by comparing the actual 
integration ratios from the 1H-NMR spectrum to the theoretical integration ratios for 
100% amidated HPEI, as demonstrated in Equation 1. For the theoretical ratio, the six 
methyl hydrogens on the amide group are multiplied by the ratio of amines available for 
modification, 0.73, and then divided by the four hydrogens from the polymer backbone. 
The actual integration ratio is found by dividing the six methyl hydrogens by the 




Theoretical Ratio : (6)(0.73)
4
=1.095
Actual Ratio : 6
10.2 "1
= 0.652







( (100%) = 60%
 
Equation 1. Calculation of percent amidation 
Of particular interest in the 13C-DEPT 135 spectrum (Figure 10), which shows       
–CH2– carbons down, and –CH– and –CH3– carbons up, are the three positive peaks. 
There are only two possibilities for these three peaks – the primary carbons and the 
methine " carbon in the isobutyryl amide groups. The peak at 18.9 ppm represents the 
methyl carbon. Thus, the two remaining peaks at 30.0 ppm and 35.0 ppm must be the 
methine carbons in two different environments; namely, bonded to either a tertiary amide 
or a secondary amide. Because a tertiary amide is bonded to two electron-donating 
groups, it is more willing to share its electrons by resonance with the carbonyl group. 
Thus, the inductive effect of the carbonyl group on the # carbon is reduced, leaving the # 
carbon with more electron density. In contrast, the secondary amide only has one 
electron-donating group and therefore does resonance with the carbonyl group to a lesser 
extent. As a result, the carbonyl group has a stronger inductive effect on the " carbon, 
increasing the partial positive charge on this carbon. Therefore, in the carbon NMR 
spectrum, the # carbon adjacent to the tertiary amide will be more shielded and farther 
upfield than the # carbon in the secondary amide group38.  
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Figure 10. 75.5 MHz 13C DEPT 135 NMR spectrum (D2O) of HPEI-IBAm0.60 (1) 
The last step in creating this thermo- and pH- responsive polymer was to 
determine the LCST at pH 7.4 (pH of the bloodstream) and pH 5 (pH within a lysosome). 
A UV/VIS spectrometer was used to determine the LCST, since the % transmittance 
decreased as the polymer became insoluble. The LCST was taken as the midpoint of the 
drop in transmittance. As can be seen in Figure 11, the LCST at pH 7.4 was at 24.0 °C 
and well below body temperature. As the acidity of the solution increased to pH 5, more 
amines became protonated, increasing the water solubility and leading to a significant 
increase in the LCST to 41.5 °C, a few degrees above body temperature.  
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Figure 11. Transmission plots of HPEI-IBAm0.60 (1) at pH 7.4 and 5 
3.2  Effects of increasing hydrophobicity on transmission 
The next step was to study the effect of increasing alkyl chain length, and thus 
increasing hydrophobicity, on the LCST. The LCST was expected to decrease as alkyl 
chain length increased, but some previous research saw a reversal in that trend for longer 
chains. When Simons studied polymers that had been propoxylated and alkylated, he 
observed that polymers with decyl functional groups had a higher LCST than polymers 
with butyl, pentyl and hexyl groups35. Winnik et al. incorporated octadecyl chains, either 
as block copolymers or pendant functional groups, into PNIPAAM and found that the 
LCST of the hydrophobically modified polymers remained fairly close to the LCST of 
PNIPAAM39. The long alkyl chains seem to be capable of folding up into micelles, with 
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the hydrophilic portion of the polymer on the outside protecting and keeping in solution 
the hydrophobic portion on the inside of the micelle39.   
A series of four polymers with increasing hydrophobicity were synthesized, 
generally following the procedures used by Simons and Skidmore35,36 (Scheme 7). In the 
initial procedures, HPEI-IBAm0.60 was dissolved in THF for these reactions. However, 
due to solubility issues, later reactions were done in EtOH, and EtOH was also added to 
the initial reactions using octyl and dodecyl groups. The reactions were done at 65 °C, 
allowing 48 hours for the initial SN2 reaction of the bromoalkanes and 24 hours for 
quenching the reactions with NaOH. Unfortunately, complete 40% alkylation did not 
occur, as 1H-NMR spectra showed alkylation at roughly 20%. For the latter, the 
calculation process will be shown later. 
Due to the lower than expected alkylation of the reactions quenched with NaOH, 
the later alkylations, using 1-bromobutane and 1-bromohexane, were attempted using 
K2CO3 as a proton trap. The reactions were done two ways – with K2CO3 present at the 
outset, and with K2CO3 added after 48 hours – with no significant difference. However, 
using K2CO3 did result in alkylation at the intended percentage.  
 
Scheme 7. Synthesis of alkylated and amidated HPEI 
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1H-NMR and 13C-DEPT 135 NMR spectroscopy were used to confirm the 
structure of the functionalized HPEI. As shown in the 1H-NMR spectrum of 2a (Figure 
12), while the peak at 1.01 ppm attributed to the methyl carbons on the amide functional 
group remained the same, new peaks developed in the aliphatic region. The peak at 0.87 
ppm corresponds to the methyl group at the end of the alkyl chain, the hydrogens farthest 
away from electron withdrawing groups and thus the most shielded. The peaks at 1.24 
ppm and 1.57 ppm represent two hydrogens, each on the carbons closer to the nitrogen. 
The last two hydrogens on the butyl chain at 1.57 ppm (peak h) – those adjacent to the 
nitrogen – are farther downfield and overlap with the peaks from the backbone 
hydrogens. 
 
Figure 12. 300 MHz 1H-NMR spectrum (D2O) of HPEI-IBAm0.60-Bu0.40 (2a) 
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The integration values from this proton NMR spectrum can also be used to 
determine percent alkylation, by calculating the theoretical values from the expected 
percentage and comparing those to the actual integration values. The theoretical values 
are determined according to Equation 2, by multiplying the number of hydrogens in each 
functional group times the expected modification ratio. The downfield hydrogens were 
set to the calculated value, and then the upfield hydrogens were integrated, giving an 
integration value of 4.88, a difference of only 0.21 from the theoretical value. 
! 
Upfield Hydrogens : (6)(0.73)(0.60) + (7)(0.73)(0.40) = 4.67
Downfield Hydrogens : 4 + (1)(0.73)(0.60) + (2)(0.73)(0.40) = 5.02
 
Equation 2. Example calculation of percent alkylation 
The same peak trends are seen in the 1H-NMR spectra for 2b, 2c, and 2d, as 
shown in Figure 13. The peak at roughly 1.24 ppm becomes more intense, compared to 
the other alkyl peaks, as the length of the carbon chain increases.  
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Figure 13. 300 MHz 1H-NMR spectral (D2O) overlay of HPEI-IBAm0.60-He0.40 (2b), 
HPEI-IBAm0.60-Oc0.24 (2c), and HPEI-IBAm0.60-DoDec0.24 (2d) 
Looking at the representative 13C-DEPT 135 NMR spectrum of 2a (Figure 14), 
two sets of peaks are significant. First, within the peaks in the aliphatic region 
corresponding to the alkyl carbons, there is considerable information. As would be 
expected, there is a positive peak at 13.2 ppm from the terminal methyl carbons, followed 
by two sets of negative peaks, at 20.2 ppm and 27.7 ppm, that represent the two middle 
carbons in the butyl chain. Second, the two peaks from the two different types of " 
carbons adjacent to the amide group are still present at 30.0 ppm and 35.0 ppm. It is 
difficult to determine from this spectrum if all the primary amines have been 
functionalized, since secondary carbons adjacent to primary amines typically give rise to 
peaks at ~ 38 ppm and ~ 40 ppm. While there is no negative peak at 40 ppm, there is still 
 43 
a peak at ~ 38 ppm, which could be due either to a carbon adjacent to a primary amine or 
to carbon g, the alkyl carbon attached to the amine.  
 
Figure 14. 75.5 MHz 13C-DEPT 135 NMR spectral overlay (D2O) of HPEI,                       
HPEI-IBAm0.60 (1), and HPEI-IBAm0.60-Bu0.40 (2a) 
An 13C inverse gated NMR spectrum, such as the one of 2a in Figure 15, allows 
these two peaks to be integrated, so that the percentage of modified primary and 
secondary amines can be determined. The ratio of 1° to 2° was found to be 1:0.747 by 
integration. So of the total primary and secondary amines available for modification, 57% 
of the amidations occurred at primary amines and 43% occurred at secondary amines. 
Even though there were a greater number of secondary amines available, the primary 
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amines are better nucleophiles since they are less sterically hindered. Thus, it is 
reasonable that a greater percentage of primary amines were modified.  
 
Figure 15. 75.5 MHz inverse gated 13C NMR spectrum (D2O) of                               
HPEI-IBAm0.60-Bu0.40 (2a) 
The solubility behavior of the alkylated polymers was analyzed, and only the 
butylated polymer was soluble above 4 °C at either pH 7.4 or pH 5. Compared to HPEI-
IBAm0.60, the LCST of HPEI-IBAm0.60-Bu0.40 decreased slightly from 24.0 °C to 22.8 °C 
at pH 7.4, and from 41.5 °C to 39.6 °C at pH 5 (Figure 16). The butyl chains are long 
enough to increase the hydrophobicity and cause aggregates to form faster, yet not 
sufficiently lengthy to coil up, form micelles, and either increase or not affect the LCST. 
However, the LCST values are still adequate for gene delivery, since the LCST at pH 7.4 
is below body temperature, meaning the polymers will form globules encapsulating the 
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genes. Yet, at pH 5, the LCST is above body temperature, allowing the polymer to open 
up and release the genes. 
 
Figure 16. Transmission plots at pH 7.4 and 5 of HPEI-IBAm0.60 (1) and                 
HPEI-IBAm0.60-Bu0.40 (2a) 
Since the amines constitute the hydrophilic part of the polymer and play an 
important role in solubility through hydrogen bonding with water, calculating the 
concentration of amines in the polymer allows further insight into the solubility behavior 
of the modified HPEI. The first step in this process was to calculate the repeat unit 
formula weight (RUFW) of the polymer, which was done by multiplying the molecular 
weight of each type of repeat unit by the ratio of that unit in the polymer. To find the 
RUFW of 1, there were two types of repeat units, amidated and unmodified HPEI, with 





Formula = (%1° + 2°amines)(%mod ification)(MW of amidated RPU)
+ (1"%mod ified)(MW of unmod ified RPU)
RUFW of 1 = (0.73)(0.60)(113.12g mol) + (0.56)(43.1g mol) = 73.8g mol
 
Equation 3. Example calculation of formula weight for HPEI-IBAm0.60 (1) 
The concentration of amines was then calculated by finding the ratio of 
millimoles of amine per gram of polymer (APG), which was found simply by taking the 















Equation 4. Example calculation of APG for HPEI-IBAm0.60 (1) 
It was postulated that an increasing APG would increase the LCST, and a plot of 
LCST vs. APG was made to visually represent the trend. The chart in Figure 17 




Figure 17. Plot of LCST vs APG for 1 and 2a at pH = 7.4 and 5. 
To include in the comparison the alkylated polymers which did not demonstrate 
an LCST above 4 °C, Table 1 was made to summarize the solubility and APG data. All 
of the polymers appear to follow the expected trend except for 2b, which has an APG of 
11.3 mmol/g. This is 0.2 mmol/g higher than 2a, yet 2a shows a significantly higher 
LCST. Part of the discrepancy is explained by the difference in % alkylation, since 2c is 
only 24% alkylated compared to the 40% alkylation of 2a, it will yield a higher than 
expected APG, since the molecular weight is lower.  It is also likely that the longer octyl 
and dodecyl chains, while not long enough to form micelles, are shielding the amines 










HPEI-IBAm0.60 (1) 13.6 24.0 41.5 
HPEI-IBAm0.60-Bu0.40 (2a) 11.1 22.8 39.6 
HPEI-IBAm0.60-He0.40 (2b) 10.4 < 4 < 4 
HPEI-IBAm0.60-Oc0.24 (2c) 11.3 < 4 < 4 
HPEI-IBAm0.60-DoDec0.24 (2d) 10.2 < 4 < 4 
 
Table 1. Table of the APGs and LCSTs of the alkylated polymers at pH 7.4 and pH 5  
3.3  Effects of rebalancing with a hydrophilic group  
Since modification with only hydrophobic groups reduced the LCST far below 
body temperature at both pH 7.4 and pH 5, the next step was to rebalance the excessive 
hydrophobicity with a hydrophilic group. While previous work done by Skidmore36 
found that the LCST increased upon addition of a hydroxyethyl group, this group was not 
studied in conjunction with hydrophobic groups. Thus, the goal was to discover what and 
how much of an effect mixing hydroxyethyl with alkyl groups would cause. 
 The addition of the hydrophilic and hydrophobic groups was accomplished step-
wise in a one-pot synthesis (Scheme 8). The synthesis of the butylated and 
hydroxyethylated polymer was done by first adding the butyl group in THF and 
quenching, then evaporating the solvent, redissolving in EtOH, and then adding the 
hydroxyethyl group and quenching. The product was purified by dialysis in DDI water. 
However, due to solubility issues, all later reactions were done completely in EtOH. 
Because previous members of this group found that alkylations occurred unevenly in 
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EtOH35, the hydroxyethylation was done first in these later syntheses. Thus, when the 
bromoalkanes were added second, they alkylated all remaining primary and secondary 
amines, obviating the problem of uneven substitution. All reactions were done at 65 °C, 
allowing 48 hours for the substitution by bromoalkanes or bromohydroxyethyl and 24 
hours for the quenching with NaOH.  
 
Scheme 8. Synthesis of amidated HPEI modified with alkyl and hydroxyethyl groups 
The structure of the polymers was confirmed with 1H-NMR and 13C-DEPT 135 
NMR spectroscopy. Using the proton spectrum of HPEI-IBAm0.60-EtOH0.20-Oc0.20 
(Figure 18) as a specific example, two features point to the expected structure. First, the 
peaks previously seen in the aliphatic region for the octylated polymer are present again 
at 0.79 ppm, 1.20 ppm, and 1.40 ppm. Second, the magnitude and multiplicity of the 
broad peaks from 2.37-4.04 ppm increases, indicating a greater number of deshielded 
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hydrogens are present. This would be consistent with where the protons from the 
hydroxyethyl group would appear. 
 
Figure 18. 300 MHz 1H-NMR spectrum (D2O) of HPEI-IBAm0.60-EtOH0.20-Oc0.20 (3c) 
The integration values from the proton spectra were again utilized to verify 
expected percent modification, following the same formula employed for calculations for 
the alkyl series. The hydrogen on the alcohol group was assumed to appear in the 
downfield peaks. The theoretical values were found to be 4.82 for the upfield peaks, and 
5.46 for the downfield peaks. The difference between the theoretical and actual value for 
the downfield hydrogens is only 0.10, confirming that the expected percent modification 
was achieved. 
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An overlay of 1H-NMR spectra of 3a, 3b, and 3d shows the same general trends, 
as seen in Figure 19. The appearance of the alkyl hydrogens in the aliphatic region is 
consistent with their previous appearance in the alkylated polymers’ proton spectra.  
 
Figure 19. 300 MHz 1H-NMR spectral (D2O) overlay of                                             
HPEI-IBAm0.64-EtOH0.18-Bu0.18 (3a) and HPEI-IBAm0.60-EtOH0.20-Oc0.20 (3c) 
13C-DEPT 135 NMR spectroscopy was used to further elucidate the structure of 
the polymers by differentiating between primary, secondary, and tertiary carbons. The 
spectrum of 3c (Figure 20) shows three important peaks sets. First, the different carbons 
in the octyl chain are more separated in the carbon spectrum than in the proton spectrum 
and give rise to three peaks. The sharp peak at 22.6 ppm is likely due to just one carbon, 
while the broader peaks at 29.3 ppm and 31.9 ppm represent the intermediary carbons in 
the alkyl chain. Second, the two different peaks attributed to the tertiary carbons bound to 
 52 
secondary and tertiary amides are still present at 30.5 ppm and 35.0 ppm. Finally, the 
carbon adjacent to the alcohol in the hydroxyethyl group is sufficiently deshielded to be 
farther downfield than the backbone carbons, with a sharp peak at 62.6 ppm.  Again, the 
peak at ~ 38 ppm is still present, while the peak at ~ 40 ppm has disappeared. It is unclear 
whether there are still primary amines present or whether the peak at ~ 38 ppm is due to a 
different type of carbon.    
 
Figure 20. 75.5 MHz 13C-DEPT 135 NMR spectral overlay (D2O) of HPEI,             
HPEI-IBAm0.60 (1), and HPEI-IBAm0.60-EtOH0.20-He0.20 (3b) 
Again, the 13C inverse gated NMR spectrum (Figure 21) allows the two methine 
" carbons to be integrated. From the integral values, the modification ratio of primary to 
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secondary amines can be calculated. The ratio is 1:0.975, which means 51% of the 
substitution reactions occurred at primary amines and 49% at secondary amines.   
 
Figure 21. 75.5 MHz inverse gated 13C NMR spectrum (D2O) of                              
HPEI-IBAm0.60-EtOH0.20-Oc0.20 (3c) 
Solutions of these polymers were then analyzed to determine the effect of the 
hydroxyethyl group on the LCST. Figure 22 depicts the surprising change in the 
behavior of the polymers containing octyl and dodecyl groups. Both polymers become 
significantly more soluble, manifesting an increase in the LCST from <4 °C to 18.5 °C 
and 19.5 °C respectively. There are two possible explanations for this behavior. First, it 
could simply be that the increased amount of hydrophilic groups capable of hydrogen 
bonding is sufficient to overcome the extreme hydrophobicity of the lengthy alkyl chains. 
Second, hydroxyethyl groups, in combination with the amines, repel the hydrophobic 
chains to a greater extent than simply the amines. Thus, in order to “hide” from the 
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hydrophilic groups, the alkyl groups could form micelles, allowing the polymer to stay in 
solution at higher temperatures.  
 
Figure 22. Transmission plot at pH 7.4 of HPEI-IBAm0.60 (1),                                    
HPEI-IBAm0.64-EtOH0.18-Bu0.18 (3a), HPEI-IBAm0.60-EtOH0.20-He0.20 (3b),              
HPEI-IBAm0.60-EtOH0.20-Oc0.20 (3c), and HPEI-IBAm0.63-EtOH0.19-DoDec0.18 (3d) 
The solubility behavior in solutions at pH 5 shows a complete reversal of the 
expected trend (Figure 23). Rather than the LCST increasing as the alky chain length 
decreases, the exact opposite occurs, with the dodecylated and hydroxethylated polymer 
demonstrating the highest LCST at 45.0 °C, compared to 41.8 °C for 3c and 40.1 °C for 
3a. In addition, compared with the curves at pH 7.4, the LCST changes more gradually at 
pH 5, with the lines manifesting slightly gentler slopes.  
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Figure 23. Transmission plot at pH 5 of HPEI-IBAm0.60 (1),                                      
HPEI-IBAm0.64-EtOH0.18-Bu0.18 (3a), HPEI-IBAm0.60-EtOH0.20-He0.20 (3b),              
HPEI-IBAm0.60-EtOH0.20-Oc0.20 (3c), and HPEI-IBAm0.63-EtOH0.19-DoDec0.18 (3d) 
To determine if this reversal was caused by a difference in APG, a chart was 
made plotting LCST vs APG at both pH 7.4 and pH 5 for the hydroxyethylated series as 
well (Figure 24). While at pH 7.4, the LCST increases as the APG increases, with the 
exception of 3c and 3d. These two have almost identical LCSTs, with 3c becoming 
insoluble at 18.5 °C and 3d becoming insoluble at 19.5 °C. However, at pH 5 the LCST 




Figure 24. Chart of LCST vs. APG for HPEI-IBAm0.60 (1),                                       
HPEI-IBAm0.64-EtOH0.18-Bu0.18 (3a), HPEI-IBAm0.60-EtOH0.20-Oc0.10 (3c),                   
and HPEI-IBAm0.63-EtOH0.19-DoDec0.18 (3d) 
As tabulated in Table 2, there is a significant difference between the APGs of the 
hydroxyethyl series. 3d is 0.73 mmol/g less than 3c, and 1.53 mmol/g less than 3b, so 
some factor other than APG must be affecting the solubility behavior. The polymers are 
more cationic at pH 5, since both the amines and the alcohol groups are protonated. Thus, 
the hydrophilic groups, to an even greater degree than in a solution of pH 7, repel the 
nonpolar hydrophobic chains. So the repulsive forces either force the polymer to remain 
in the extended coil conformation for longer, or they again encourage the formation of 
micelles, concealing the alkyl chains and allowing the enthalpic forces to retain control at 









HPEI-IBAm0.60 (1) 13.6 24.0 41.5 
HPEI-IBAm0.64-EtOH0.18-Bu0.18 (3a) 11.2 22.7 40.1 
HPEI-IBAm0.60-EtOH0.20-He0.20 (3b) 10.8 22.1 45.4 
HPEI-IBAm0.60-EtOH0.20-Oc0.20 (3c) 10.4 18.5 41.8 
HPEI-IBAm0.63-EtOH0.19-DoDec0.18 (3d) 9.67 19.5 45.0 
 
Table 2. Table of the APGs and LCSTs of the hydroxyethylated and alkylated polymers 
at pH 7.4 and pH 5 
3.4  Effects of PEG on transmission 
As mentioned previously, PEI modified with PEG tends to have reduced 
cytotoxicity. So the final polymer series was functionalized with low molecular weight 
PEG, containing 16 repeat units, and alkyl chains. The goal was to lower cytotoxicity and 
to determine what effect the long hydrophilic PEG chains would have on solubility 
behavior. Burgy et al. performed a substitution reaction with PEG and sodium azide in 
the microwave using an EtOH/H2O mix as the solvent40. In the current research, the 
reaction to substitute PEG was first done in EtOH and quenched with NaOH, following 
the same procedure for hydroxyethylation and using poly(ethylene glycol) methyl ether 
tosylate (TPEG) as the substrate. However, this resulted in only ~10% PEGylation, rather 
than the intended 40%. Since TPEG is highly susceptible to hydrolysis, the reaction was 
probably wet and TPEG was hydrolyzed before the amine could react with it. 
Rivera et al first converted the tosyl group on TPEG to an iodide group and then 
performed the substitution reaction in DMF with aniline as the nucleophile and Na2CO3 
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as the proton trap41. However, an analogous reaction with HPEI-IBAm0.60 as the 
nucleophile is not possible as the polymer is not soluble in DMF, nor most other common 
anhydrous solvents, except for DMSO. Since DMSO is aprotic and polar, it facilitates 
SN2 reactions. In the current research, the reaction was next performed in distilled 
DMSO, using K2CO3 as a proton trap, at 65 °C for 72 hours (Scheme 9). The product 
was purified in aqueous dialysis. While PEGylation at the intended 40% was never 
achieved, the percent modification did improve significantly to 25%. 
 
Scheme 9. Synthesis of PEG-modified HPEI-IBAm0.60 
1H-NMR spectroscopy was used to confirm the structure and to calculate percent 
modification with PEG. Since all the hydrogens in PEG are adjacent to oxygen, they are 
deshielded by the electron withdrawing nature of oxygen and appear downfield from the 
aliphatic region. In the spectrum of HPEI-IBAm0.60-PEG0.25 (Figure 25), a very intense, 
sharp peak appears at 3.64 ppm, representing the hydrogens in PEG. Slightly upfield at 
3.32 ppm is another sharp peak, but with a much weaker signal, which is attributed to the 
methyl group attached to an oxygen atom at the end of PEG.  
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Figure 25. 300 MHz 1H-NMR spectrum (D2O) of HPEI-IBAm0.60-PEG0.25 (4) 
Percent modification was calculated by finding the ratio of the actual integration 
for the main PEG peak to the theoretical integration value for this peak (Equation 5). 
The methyl peak at 1.02 ppm was a known value, which was calculated by multiplying 
the six hydrogens it represents by their known percent modification (Equation 5). 
! 
Integration value of methyl hydrogens : (0.73)(0.60)(6Hs) = 2.63
Theoretical integration value of PEG peak : (0.73)(0.40)(64Hs) =18.7







' (40% theoreticalmod ification)(100%) = 25%
 
 Equation 5. Calculation of percent modification with PEG 
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A 13C-DEPT 135 NMR spectrum was also obtained to confirm the structure 
(Figure 26). The intense peak at 69.6 ppm represents the secondary carbons in the PEG 
chain, confirming successful modification with PEG. The methoxy signal is also present 
at 58.1 ppm, as are the two peaks attributed to the two different tertiary carbon atoms of 
isobutyryl amide groups at 29.9 ppm and 35.1 ppm.  
 
Figure 26. 75.5 MHz 13C-DEPT 135 NMR spectrum (D2O) of                                  
HPEI-IBAm0.60-PEG0.25 (4) 
Next, the PEG-functionalized amidated HPEI was modified with alkyl groups to 
finish covering the primary amines and to determine if the series of PEG-alkyl polymers 
would follow the same trends as the hydroxyethyl-alkyl polymers. The reactions followed 
the same general procedure as previous alkylations (Scheme 10) except that EtOH was 
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used as the solvent, and K2CO3 was used as the base, rather than NaOH. For the addition 
of butyl, the proton trap was added from the beginning. However, for the additions of 
octyl and dodecyl, K2CO3 was added after 48 hours to protect against deprotonation and 
substitution at the amide nitrogen. The reaction continued for 24 hours after the addition 
of the proton trap, and then was purified in aqueous dialysis.  
 
 Scheme 10. Synthesis of HPEI-IBAm0.60 modified with PEG and alkyl groups 
The structures were confirmed with 1H-NMR spectroscopy, which showed a 
combination of the peaks seen previously from alkyl groups and PEG groups (Figure 
27). The expected two new aliphatic peaks are present at 0.84 ppm and 1.23 ppm, while 
the methoxy peak from PEG appears at 3.31 ppm and the PEG chain hydrogens give rise 
to a peak at 3.62 ppm. The proton spectrum also confirmed the expected percent 
alkylation. The integration value of the PEG peak at 3.62 ppm was adjusted to the same 
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number it was integrated at in the spectrum of 4. Then the aliphatic peaks were integrated 
in reference to the PEG peak, and that value was compared to the calculated value, found 
following the formula in Equation 2.  The theoretical value was 5.48, only 0.06 less than 
the actual value. So the actual percent modification with dodecyl was very close to the 
theoretical percentage.  
 
Figure 27. 300 MHz 1H-NMR spectrum (D2O) of                                                        
HPEI-IBAm0.60-PEG0.23-DoDec0.17 (4d) 
The proton spectra of 4a and 4c (Figure 28) follow the same pattern, showing 
both the uniquely sharp and intense PEG peaks downfield and the broader alkyl peaks 
upfield. As the ratio of PEG hydrogens to alkyl hydrogens increases, the magnitude of the 




Figure 28. 300 MHz 1H-NMR spectral (D2O) overlay of                                                
HPEI-IBAm0.60-PEG0.23-Bu0.17 (4a) and HPEI-IBAm0.60-PEG0.25-Oc0.15 (4d) 
The 13C-DEPT 135 NMR spectrum (Figure 29) of 4a manifests the characteristic 
peaks of both PEG and butyl. The butyl methyl group is at 13.4 ppm and the two middle 
carbons in a broad peak at 25.2 ppm. The two carbons associated with the secondary and 
tertiary amides are found at 30.0 ppm and 35.0 ppm. Finally, the secondary carbons in the 
PEG chain give rise to a sharp peak at 70.0 ppm, while the methoxy group causes a 
smaller peak at 58.0 ppm.  
 64 
 
Figure 29. 75.5 MHz 13C-DEPT 135 NMR spectrum (D2O) of                                               
HPEI-IBAm0.60-PEG0.23-Bu0.17 (4a) 
Again, the 13C inverse gated NMR spectrum (Figure 30) allows the two methine 
" carbons to be integrated. From the integral values, the modification ratio of primary to 
secondary amines can be calculated. The ratio is 1:1.18, which means 46% of the 
substitution reactions occurred at primary amines and 54% at secondary amines.   
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Figure 30. 75.5 MHz inverse gated 13C NMR spectrum (D2O) of                                           
HPEI-IBAm0.60-PEG0.23-Bu0.17 (4a) 
When the solubility behavior of the PEGylated polymers was studied at pH 7.4, 
all of the polymers in this series had an LCST higher than that of HPEI-IBAm0.60, as 
would be expected given the great increase in hydrophilicity caused by PEG (Figure 31). 
However, somewhat surprisingly, with LCSTs at 29.2 °C and 26.4 °C respectively, the 
butylated and dodecylated polymers remained in solution longer than either the octylated 
polymer or the polymer functionalized with PEG only, with LCSTs at 25.2 °C and 25.5 
°C. It would seem that the butyl chain is small enough that the PEG chains effectively 
hide the nonpolar group from the surrounding solution. The dodecyl group, repelled by 
the increasing hydrophilicity caused by the PEG chain, is long enough to coil inwards 
and form micelles protected by the hydrophilic segments. The octyl group is caught in 
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between, neither short enough to be hidden while extended, nor long enough to coil as 
efficiently as the dodecyl chain. There does still seem to be some shielding of the octyl 
chain, since its LCST is barely lower than the LCST of 4. Compared to the 
hydroxyethylated series, the micellar effect seems to be enhanced, probably due to the 
greater hydrophilicity of PEG compared to the short hydroxyethyl group.  
 
Figure 31. Transmission plot at pH 7.4 of HPEI-IBAm0.60 (1),                                      
HPEI-IBAm0.60-PEG0.23 (4), HPEI-IBAm0.60-PEG0.23-Bu0.17 (4a),                              
HPEI-IBAm0.60-PEG0.25-Oc0.15 (4c), and HPEI-IBAm0.60-PEG0.23-DoDec0.17 (4d) 
The solubility was also studied at pH 5, and the results are seen in Figure 32. As 
the alkyl character of the polymers increased, the slopes of the lines became much 
smaller as the change in solubility occurred more gradually. Here again, as was seen in 
the hydroxyethylated series, the trend reverses and 4d has the highest LCST at 74.0 °C, 
then 4c at 62.8 °C, then 4a at 55.5 °C, followed by 4 with the lowest LCST at 46.5 °C. 
The increasing cationic, and thus hydrophilic, nature of the polymer at pH 5 repulses the 
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longer hydrophilic chains to a greater degree than at pH 7.4. Thus, while butyl was 
hidden by virtue of being short at the lower pH, at pH 5 it is too short to coil and thus 
cannot be concealed as easily as the octyl and dodecyl chains. At pH 5, the increasing 
difference between polar and nonpolar groups gives the octyl and dodecyl groups added 
impetus to form micelles, thus increasing the formation of micelles and increasing the 
LCST as the hydrophobic groups are more hidden.  
 
Figure 32. Transmission plot at pH 5 of HPEI-IBAm0.60 (1),                                      
HPEI-IBAm0.60-PEG0.23 (4), HPEI-IBAm0.60-PEG0.23-Bu0.17 (4a),                              
HPEI-IBAm0.60-PEG0.25-Oc0.15 (4c), and HPEI-IBAm0.60-PEG0.23-DoDec0.17 (4d) 
To determine if the unexpected trends might be due to the concentration of 
amines, APG values were calculated and plotted against the LCSTs (Figure 33). The 
concentration of amines in the PEGylated series is much lower than in previous series 
due to the great increase in molecular weight caused by the addition of PEG.  
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Figure 33. Chart of LCST vs APG for HPEI-IBAm0.60 (1),                                        
HPEI-IBAm0.60-PEG0.23 (4), HPEI-IBAm0.60-PEG0.23-Bu0.17 (4a),                              
HPEI-IBAm0.60-PEG0.25-Oc0.15 (4c), and HPEI-IBAm0.60-PEG0.23-DoDec0.17 (4d) 
Looking at the actual values for the APG in Table 3, the APG generally decreases 
as the alkyl chain length increases. 4c has a slightly higher APG than 4d, because it 
contains a slightly greater percentage of PEG. At pH 7.4, there is not a clear trend in the 
relation between APG and LCST, due to the varying behavior of the hydrophobic groups. 
At pH 5, the APG and LCST values are inversely related, contrary to expectation. 
However, in solution at both pH 7.4 and pH 5, as micelles form, the actual concentration 
of amines would appear greater than the theoretical values. Thus, the solubility behavior 
is still dependent on the ability and freedom of the amines to form hydrogen bonds with 










HPEI-IBAm0.60 (1) 13.6 24.0 41.5 
HPEI-IBAm0.64-PEG0.23 (4) 5.55 25.5 46.5 
HPEI-IBAm0.60-PEG0.23-Bu0.17 (4a) 4.93 29.2 55.5 
HPEI-IBAm0.60-PEG0.25-Oc0.15 (4c) 4.57 25.2 62.8 
HPEI-IBAm0.60-PEG0.23-DoDec0.17 (4d) 4.61 26.4 74.0 
 
Table 3. Table of the APGs and LCSTs of the PEGylated and alkylated polymers at     
pH 7.4 and pH 5 
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4.  CONCLUSION 
Three series of modified HPEI polymers were prepared. First, a series of polymers 
with increasing hydrophobicity, 2a-2d, were synthesized. The influence of the alkyl chain 
length on solubility behavior was analyzed. Of the four polymers, only the butylated 
polymer demonstrated an observable LCST at either pH 7.4 or pH 5. Since the LCST at 
pH 7.4 was below body temperature and at pH 5 was above body temperature, this 
polymer is suitable for gene delivery as it displays the desired change in conformation. 
However, for the remaining three polymers, while the majority of primary amines were 
successfully hidden, the polymers are not good candidates for gene delivery, since they 
do not exhibit a change in conformation in response to temperature or pH.  
Second, a series of polymers tempering the hydrophobicity with a hydroxyethyl 
group, 3a-3d, were prepared. Finally, a series of polymers modified with a mixture of 
PEG and alkyl chains, 4-4d, were synthesized. Again, the effect of temperature on the 
LCST was studied. All of the polymers in both series, at both pH 7.4 and pH 5, exhibited 
LCSTs that were below body temperature in the neutral environment and above body 
temperature in the acidic environment. So all of the polymers from these two series have 
potentially low cytotoxicity and are high efficiency gene delivery vectors, since the 
majority of the primary amines are modified to secondary amines and they do switch 
conformation from extended coil to globule in response to temperature and pH stimuli.  
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5.  FUTURE WORK 
In order to verify the ability of these modified HPEI polymers to serve as effective 
gene delivery vectors, transfection studies need to be performed, with different cell lines 
and varying polymer/DNA ratios. A better method for introducing PEG onto HPEI-
IBAm0.60, in order to accomplish complete 40% PEGylations, should be developed. Also, 
an amidated polymer modified with 20% PEG and 20% hexyl should be synthesized for 
further elucidation of the relationship between APG and LCST. Finally, since 
overexpression of folate and glucose receptors is common in cancer cells, methods for 
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